Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire
<h3>Background</h3><p dir="ltr">Since the emergence of the COVID-19 pandemic, vaccines have been developed to tackle the disease. However, many people worldwide were not confident enough to take the vaccines. Developing a questionnaire to measure COVID-19 vaccine hesitanc...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513528828788736 |
|---|---|
| author | Hamed Hammoud (9639309) |
| author2 | Soha S. Albayat (17430936) Jesha Mundodan (17869370) Saif Alateeg (17869373) Nada Adli (15898914) Doaa Sabir (17869376) Tasneem Bendari (17869379) Hamad E. Al-Romaihi (9913221) Iheb Bougmiza (8962583) |
| author2_role | author author author author author author author author |
| author_facet | Hamed Hammoud (9639309) Soha S. Albayat (17430936) Jesha Mundodan (17869370) Saif Alateeg (17869373) Nada Adli (15898914) Doaa Sabir (17869376) Tasneem Bendari (17869379) Hamad E. Al-Romaihi (9913221) Iheb Bougmiza (8962583) |
| author_role | author |
| dc.creator.none.fl_str_mv | Hamed Hammoud (9639309) Soha S. Albayat (17430936) Jesha Mundodan (17869370) Saif Alateeg (17869373) Nada Adli (15898914) Doaa Sabir (17869376) Tasneem Bendari (17869379) Hamad E. Al-Romaihi (9913221) Iheb Bougmiza (8962583) |
| dc.date.none.fl_str_mv | 2023-08-01T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1016/j.jvacx.2023.100286 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Development_and_validation_of_a_multi-dimensional_COVID-19_vaccine_hesitancy_questionnaire/25107611 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Clinical sciences Immunology Health sciences Epidemiology Public health COVID-19 Vaccine hesitancy Vaccine Confidence Validation Factor analysis Vaccine hesitancy scale |
| dc.title.none.fl_str_mv | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Background</h3><p dir="ltr">Since the emergence of the COVID-19 pandemic, vaccines have been developed to tackle the disease. However, many people worldwide were not confident enough to take the vaccines. Developing a questionnaire to measure COVID-19 vaccine hesitancy will give the health authorities and policymakers a clear picture to establish appropriate interventions addressing vaccine hesitancy among the community.</p><h3>Methods</h3><p dir="ltr">In this study, we used a mixed-method design over two phases. Phase 1 entailed a qualitative approach to developing the questionnaire, including a literature search, expert panel review, and focus group discussion. Phase 2 used a quantitative method for establishing the content and construct validity of the questionnaire via exploratory and confirmatory factor analysis (EFA & CFA). Internal consistency was checked using Cronbach's Alpha and intraclass correlation coefficient.</p><h3>Results</h3><p dir="ltr">We developed a 50-item instrument designed to measure COVID-19 vaccine hesitancy among adults in the state of Qatar. The study involved 545 adult participants. In terms of content validity, our study showed a value of 0.92 for the scale-level content validity index based on the average and a value of 0.76 for the scale-level content validity index - universal agreement. In the EFA, the Kaiser-Meyer-Olkin measure of sampling adequacy was calculated at 0.78, with statistical significance (P = 0.001). Regarding model fit indices of the seven-factor model, our findings showed an acceptable model-data-fit, with a relative chi-square: 1.7 (<3), Root mean square error of approximation: 0.05 (<0.08), PCLOSE = 0.41, Comparative fit index: 0.909, Tucker-Lewis index: 0.902, Incremental Fit Index: 0.910 and, Standardized Root mean square residual: 0.067 (<0.08). The seven-factor model of the questionnaire met the criterion of good internal consistency (Cronbach's alpha = 0.73).</p><h3>Conclusion</h3><p dir="ltr">This tool is deemed of methodological merits in terms of validity, reliability, and determining the underlying conceptual structure of COVID-19 vaccine hesitancy and its associating factors.</p><h2>Other Information</h2><p dir="ltr">Published in: Vaccine: X<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.jvacx.2023.100286" target="_blank">https://dx.doi.org/10.1016/j.jvacx.2023.100286</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_ecd965031453aafad05bcf49afb8bcbc |
| identifier_str_mv | 10.1016/j.jvacx.2023.100286 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/25107611 |
| publishDate | 2023 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaireHamed Hammoud (9639309)Soha S. Albayat (17430936)Jesha Mundodan (17869370)Saif Alateeg (17869373)Nada Adli (15898914)Doaa Sabir (17869376)Tasneem Bendari (17869379)Hamad E. Al-Romaihi (9913221)Iheb Bougmiza (8962583)Biomedical and clinical sciencesClinical sciencesImmunologyHealth sciencesEpidemiologyPublic healthCOVID-19Vaccine hesitancyVaccine ConfidenceValidationFactor analysisVaccine hesitancy scale<h3>Background</h3><p dir="ltr">Since the emergence of the COVID-19 pandemic, vaccines have been developed to tackle the disease. However, many people worldwide were not confident enough to take the vaccines. Developing a questionnaire to measure COVID-19 vaccine hesitancy will give the health authorities and policymakers a clear picture to establish appropriate interventions addressing vaccine hesitancy among the community.</p><h3>Methods</h3><p dir="ltr">In this study, we used a mixed-method design over two phases. Phase 1 entailed a qualitative approach to developing the questionnaire, including a literature search, expert panel review, and focus group discussion. Phase 2 used a quantitative method for establishing the content and construct validity of the questionnaire via exploratory and confirmatory factor analysis (EFA & CFA). Internal consistency was checked using Cronbach's Alpha and intraclass correlation coefficient.</p><h3>Results</h3><p dir="ltr">We developed a 50-item instrument designed to measure COVID-19 vaccine hesitancy among adults in the state of Qatar. The study involved 545 adult participants. In terms of content validity, our study showed a value of 0.92 for the scale-level content validity index based on the average and a value of 0.76 for the scale-level content validity index - universal agreement. In the EFA, the Kaiser-Meyer-Olkin measure of sampling adequacy was calculated at 0.78, with statistical significance (P = 0.001). Regarding model fit indices of the seven-factor model, our findings showed an acceptable model-data-fit, with a relative chi-square: 1.7 (<3), Root mean square error of approximation: 0.05 (<0.08), PCLOSE = 0.41, Comparative fit index: 0.909, Tucker-Lewis index: 0.902, Incremental Fit Index: 0.910 and, Standardized Root mean square residual: 0.067 (<0.08). The seven-factor model of the questionnaire met the criterion of good internal consistency (Cronbach's alpha = 0.73).</p><h3>Conclusion</h3><p dir="ltr">This tool is deemed of methodological merits in terms of validity, reliability, and determining the underlying conceptual structure of COVID-19 vaccine hesitancy and its associating factors.</p><h2>Other Information</h2><p dir="ltr">Published in: Vaccine: X<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.jvacx.2023.100286" target="_blank">https://dx.doi.org/10.1016/j.jvacx.2023.100286</a></p>2023-08-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.jvacx.2023.100286https://figshare.com/articles/journal_contribution/Development_and_validation_of_a_multi-dimensional_COVID-19_vaccine_hesitancy_questionnaire/25107611CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/251076112023-08-01T00:00:00Z |
| spellingShingle | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire Hamed Hammoud (9639309) Biomedical and clinical sciences Clinical sciences Immunology Health sciences Epidemiology Public health COVID-19 Vaccine hesitancy Vaccine Confidence Validation Factor analysis Vaccine hesitancy scale |
| status_str | publishedVersion |
| title | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire |
| title_full | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire |
| title_fullStr | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire |
| title_full_unstemmed | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire |
| title_short | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire |
| title_sort | Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire |
| topic | Biomedical and clinical sciences Clinical sciences Immunology Health sciences Epidemiology Public health COVID-19 Vaccine hesitancy Vaccine Confidence Validation Factor analysis Vaccine hesitancy scale |